21 CFR 119.1 - Dietary supplements containing ephedrine alkaloids

Cite as21 CFR 119.1
    • This document is available in original version only for vLex customers

      View this document and try vLex for 7 days
    • TRY VLEX
11 practice notes
  • Part II
    • United States
    • Federal Register June 25, 2007
    • June 25, 2007
    ...to proposed Sec. 111.125(b). 3. Final Sec. 111.605(c) Final Sec. 111.605(c) requires that all electronic records comply with part 11 (21 CFR part 11). Final Sec. 111.605(c) derives from proposed Sec. [[Page 34913]] (Comment 327) One comment believes part 11 should only apply to records that......
  • Food for human consumption: Current good manufacturing practice— Dietary supplements; manufacturing, packaging, labeling, or holding operations,
    • United States
    • Federal Register June 25, 2007
    • June 25, 2007
    ...to proposed Sec. 111.125(b). 3. Final Sec. 111.605(c) Final Sec. 111.605(c) requires that all electronic records comply with part 11 (21 CFR part 11). Final Sec. 111.605(c) derives from proposed Sec. [[Page 34913]] (Comment 327) One comment believes part 11 should only apply to records that......
  • Nve, Inc. v. Department of Health and Human Serv., No. 04-4481.
    • United States
    • United States Courts of Appeals. United States Court of Appeals (3rd Circuit)
    • February 7, 2006
    ...that dietary supplements containing ephedrine alkaloids ("EDS") were adulterated under the "unreasonable risk" standard of DSHEA. 21 C.F.R. § 119.1. The effect of the regulation was to prohibit the distribution of these supplements. NVE, a former manufacturer and distributor of EDS, brought......
  • 4 OTC, Inc.; Decision and Order
    • United States
    • Federal Register June 12, 2012
    • June 12, 2012
    ...delivery, or the receipt of an adulterated product in interstate commerce. 21 U.S.C. 331 (a)-(c). See 69 FR 6,788 (FDA 2003); 21 C.F.R 119.1 (2010). The FDA further prohibits the marketing of a bronchodilator as a dietary supplement as such constitutes misbranding. 21 U.S.C. 331(b). Consequ......
  • Request a trial to view additional results
6 cases
  • Nve, Inc. v. Department of Health and Human Serv., No. 04-4481.
    • United States
    • United States Courts of Appeals. United States Court of Appeals (3rd Circuit)
    • February 7, 2006
    ...containing ephedrine alkaloids ("EDS") were adulterated under the "unreasonable risk" standard of DSHEA. 21 C.F.R. § 119.1. The effect of the regulation was to prohibit the distribution of these supplements. NVE, a former manufacturer and distributor of EDS, brought this......
  • Giordano v. Mkt. Am. Inc, Docket No. 06-2071-cv.
    • United States
    • United States Courts of Appeals. United States Court of Appeals (2nd Circuit)
    • March 17, 2010
    ...banned ephedra by declaring dietary supplements[599 F.3d 91]containing ephedrine alkaloids "adulterated" under the FDCA. See 21 C.F.R. § 119.1; Final Rule Declaring Dietary Supplements Containing Ephedrine Alkaloids Adulterated Because They Present an Unreasonable Risk ("FDA ......
  • U.S. v. 5 Unlabeled Boxes, No. 07-4352.
    • United States
    • United States Courts of Appeals. United States Court of Appeals (3rd Circuit)
    • July 14, 2009
    ...the manufacturer bears the burden of proving that the drug or device is safe before it may be marketed. 3. The Rule is codified at 21 C.F.R. § 119.1 and provides: "Dietary supplements containing ephedrine alkaloids present an unreasonable risk of illness or injury under conditions of u......
  • United States v. Chan, No. 16-17797
    • United States
    • United States Courts of Appeals. United States Court of Appeals (11th Circuit)
    • April 4, 2018
    ...In 2004 the Food and Drug Administration banned dietary supplements containing ephedrine by deeming them "adulterated foods." 21 C.F.R. § 119; see 21 U.S.C. § 331(a) (prohibiting introduction of adulterated foods into interstate commerce). Because ephedrine can be used to make met......
  • Request a trial to view additional results

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT